Onkos Surgical announced completion of the first ELEOS™ Limb Salvage procedure using uDesign™ Patient Solutions.
The uDesign interactive experience supports personalized planning for patients to visualize the surgical plan and also ensure that Onkos delivers the right bundle of products for a procedure.
Onkos received FDA 510(k) clearance in 4Q16 to market ELEOS to treat bone loss due to cancer, trauma or previous surgery.
Sources: Onkos Surgical; ORTHOWORLD Inc.
Onkos Surgical announced completion of the first ELEOS™ Limb Salvage procedure using uDesign™ Patient Solutions.
The uDesign interactive experience supports personalized planning for patients to visualize the surgical plan and also ensure that Onkos delivers the right bundle of products for a procedure.
Onkos received FDA 510(k) clearance...
Onkos Surgical announced completion of the first ELEOS™ Limb Salvage procedure using uDesign™ Patient Solutions.
The uDesign interactive experience supports personalized planning for patients to visualize the surgical plan and also ensure that Onkos delivers the right bundle of products for a procedure.
Onkos received FDA 510(k) clearance in 4Q16 to market ELEOS to treat bone loss due to cancer, trauma or previous surgery.
Sources: Onkos Surgical; ORTHOWORLD Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.